Evaxion A (EVAX) Total Liabilities (2019 - 2026)
Evaxion A (EVAX) posted Total Liabilities of $10.4 million for Q1 2026, down 8.22% on a QoQ basis from $11.4 million in Q4 2025, and down 29.95% year-over-year from $14.9 million in Q1 2025.
Evaxion A (EVAX) Total Liabilities (2019 - 2026) Analysis & Trends
Evaxion A's Total Liabilities history runs 8 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- Quarterly Total Liabilities fell 29.95% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (down 29.95% YoY) and the FY2025 annual result came in at $11.4 million, down 19.58% from the prior year.
- Total Liabilities was $10.4 million for Q1 2026 at Evaxion A, down from $11.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $16.2 million in Q2 2025 and bottomed at $20050.0 in Q1 2024.
- A 5-year average of $11.3 million and a median of $13.9 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities plunged 99.86% — and 2025, when it jumped 74194.26%.
- Evaxion A's Total Liabilities stood at $573000.0 in 2022, then slumped by 66.84% to $190000.0 in 2023, then jumped by 7340.53% to $14.1 million in 2024, then slipped by 19.58% to $11.4 million in 2025, then fell by 8.22% to $10.4 million in 2026.
- Business Quant data shows EVAX's Total Liabilities at $10.4 million in Q1 2026, $11.4 million in Q4 2025, and $13.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | 10.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.44 Mn |
| Dec 31, 2025 | 11.37 Mn |
| Sep 30, 2025 | 13.14 Mn |
| Jun 30, 2025 | 16.22 Mn |
| Mar 31, 2025 | 14.90 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Jun 30, 2024 | 13.98 Mn |
| Mar 31, 2024 | 20,050.00 |
| Dec 31, 2023 | 190,000.00 |
| Sep 30, 2023 | 14.68 Mn |
| Jun 30, 2023 | 14.22 Mn |
| Mar 31, 2023 | 13.91 Mn |
| Dec 31, 2022 | 573,000.00 |
| Sep 30, 2022 | 13.90 Mn |
| Jun 30, 2022 | 13.85 Mn |
| Mar 31, 2022 | 14.69 Mn |
| Dec 31, 2021 | 7.73 Mn |
| Sep 30, 2021 | 7.47 Mn |
| Jun 30, 2021 | 5.83 Mn |
| Mar 31, 2021 | 7.12 Mn |